Department of Special Surgery, University of Jordan Hospital, the University of Jordan , Amman, Jordan.
Internship, Jordanian Royal Medical Services , Amman, Jordan.
Ophthalmic Epidemiol. 2020 Aug;27(4):259-264. doi: 10.1080/09286586.2020.1723114. Epub 2020 Feb 3.
Sickle cell disease is an inherited hematological disorder that can affect any organ in the body including the eyes (1-6). Previous studies on ocular manifestations of sickle cell disease generally included samples of less than 100 patients. In this study, we aim to assess the frequency of different ocular signs, symptoms and complications among sickle cell disease patients.
This study was conducted using data from the Cooperative Study of Sickle Cell Disease (CSSCD). Patients with major sickle cell hemoglobinopathies (SS, SC, S β-thal) were eligible for enrollment. Patients from all age groups were included. Patients underwent detailed ophthalmological examination under standardized conditions.
A total of 1904 patients were included in this study, with a mean age of 27.67 (±11.72) years. 1,802 (96.4%) patients had BCVA of more than 20/40 in the better-seeing eye. On slit lamp examination, the presence of vascular loops and segment, representing a positive conjunctival sign, was the most common reported abnormal finding (54.1%). The most common complication was peripheral retinal artery occlusion detected in225 patients (20.3%) bilaterally and 77 patients (6.9%) unilaterally.
In this study that included one of the largest samples ever studied to assess ocular complications of sickle cell disease, we identified the frequency and percentages of different ocular signs, symptoms and complications in different age groups.
镰状细胞病是一种遗传性血液病,可影响身体的任何器官,包括眼睛(1-6)。以前关于镰状细胞病眼部表现的研究一般包括不到 100 例患者的样本。在这项研究中,我们旨在评估镰状细胞病患者不同眼部体征、症状和并发症的频率。
本研究使用合作镰状细胞病研究(CSSCD)的数据进行。有主要镰状细胞血红蛋白病(SS、SC、Sβ-地中海贫血)的患者有资格入组。所有年龄组的患者均包括在内。患者在标准化条件下接受详细的眼科检查。
这项研究共纳入 1904 例患者,平均年龄为 27.67(±11.72)岁。1802 例(96.4%)患者在较好的一眼中视力大于 20/40。在裂隙灯检查中,血管环和节段的存在,代表阳性结膜征,是最常见的异常发现(54.1%)。最常见的并发症是周边视网膜动脉阻塞,225 例患者(20.3%)双侧和 77 例患者(6.9%)单侧。
在这项研究中,我们纳入了有史以来评估镰状细胞病眼部并发症的最大样本之一,确定了不同年龄组不同眼部体征、症状和并发症的频率和百分比。